Researchmoz added Most up-to-date research on "Global Asthma & COPD Market Report: 2015 Edition" to its huge collection of research reports.
Asthma is a common chronic disease linking the airway in the lungs that affects the people of all age groups. The airways or bronchial tubes, allow air to come in and out of the lungs. The airway of asthmatic patients is generally inflamed and becomes swollen over time. This makes it difficult for air to move in and out of the lungs, causing symptoms such as coughing, wheezing, shortness of breath and/ or chest tightness.
The prevalence of asthma is expected to increase significantly in the coming years. The market for asthma drugs is driven by various factors including increasing global spending on medicines, increasing tobacco and cigarette consumption, rising prevalence of non-communicable diseases, more use of biologics, and increasing healthcare expenditure worldwide. The major upcoming trends in the asthma market include introduction of new severe asthma and Chronic Obstructive Pulmonary Disease (COPD) drugs, and introduction of new mechanisms that will help drive the market. However, there are certain challenges hindering the growth of the market. Such challenges include increased pricing pressures, patent expiries and introduction of generic drugs in the market.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=363110
The market for asthma and COPD drugs represents an area of potential opportunity in both developed and developing countries. Due to effectiveness and advancements in technology, a large number of companies are focusing to develop innovative asthma and COPD drugs and treatments. Further, the companies are combining businesses and spending comprehensively on research and development to develop effective treatment methods for asthma.
The present report provides a comprehensive analysis of the global asthma & COPD market with focus on regions like the U.S. and European Union. Furthermore, market dynamics such as the industry trends and development, the underlying growth drivers and major issues faced by the industry are elicited. On the contention front, the market is personified by the intense competition in terms of research and development of novel therapeutic molecules. The leading players operating in the industry include AstraZeneca, Merck and Co., Roche, Sanofi and Novartis which are also profiled in this report.
Table of Content
1. Overview1.1 Definition of Asthma
1.2 Types of Asthma
1.3 Triggers of Asthma
1.4 Treatment Options for Asthma
1.5 Chronic Obstructive Pulmonary Disease (COPD)
1.5.1 Difference between Asthma and COPD
1.5.2 Treatment Options for COPD
2. Market Analysis
2.1 Global Respiratory Market
Market Value
Market Segments
Regional Breakdown
2.1.1 Global Respiratory Therapeutics Market
Market Value
Product Segmentation
2.1.2 Global Inhalation Drug Delivery Technologies Market
Market Value
Product Segmentation
2.2 Global Asthma/COPD Market
Market Value
Prevalence Rate
Regional Breakdown
2.2.1 Global Asthma/COPD Therapeutics Market
2.3 Global Severe Asthma Market
3. Regional Markets
3.1. The U.S.
Market Overview
Diagnosed/Treated Population
3.2 European Union
Market Overview
Diagnosed/Treated Population
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Growing Global Spending on Medicines
4.1.2 Cigarette and Tobacco Consumption
4.1.3 Rising Prevalence of Non Communicable Diseases
4.1.4 Increasing Use of Biologic Drugs
4.1.5 Escalating Global GDP
4.1.6 Global Healthcare Expenditure
4.2 Key Trends and Developments
4.2.1 Launch of New Severe Asthma Drugs
4.2.2 Introduction of New COPD Drugs
4.3 Challenges
4.3.1 Increased Pricing Pressure
4.3.2 Patent Expiries and Generic Drugs
5. Competitive Landscape
5.1 Global Respiratory Market
5.2 Global Severe Asthma Market
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=363110
Asthma is a common chronic disease linking the airway in the lungs that affects the people of all age groups. The airways or bronchial tubes, allow air to come in and out of the lungs. The airway of asthmatic patients is generally inflamed and becomes swollen over time. This makes it difficult for air to move in and out of the lungs, causing symptoms such as coughing, wheezing, shortness of breath and/ or chest tightness.
The prevalence of asthma is expected to increase significantly in the coming years. The market for asthma drugs is driven by various factors including increasing global spending on medicines, increasing tobacco and cigarette consumption, rising prevalence of non-communicable diseases, more use of biologics, and increasing healthcare expenditure worldwide. The major upcoming trends in the asthma market include introduction of new severe asthma and Chronic Obstructive Pulmonary Disease (COPD) drugs, and introduction of new mechanisms that will help drive the market. However, there are certain challenges hindering the growth of the market. Such challenges include increased pricing pressures, patent expiries and introduction of generic drugs in the market.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=363110
The market for asthma and COPD drugs represents an area of potential opportunity in both developed and developing countries. Due to effectiveness and advancements in technology, a large number of companies are focusing to develop innovative asthma and COPD drugs and treatments. Further, the companies are combining businesses and spending comprehensively on research and development to develop effective treatment methods for asthma.
The present report provides a comprehensive analysis of the global asthma & COPD market with focus on regions like the U.S. and European Union. Furthermore, market dynamics such as the industry trends and development, the underlying growth drivers and major issues faced by the industry are elicited. On the contention front, the market is personified by the intense competition in terms of research and development of novel therapeutic molecules. The leading players operating in the industry include AstraZeneca, Merck and Co., Roche, Sanofi and Novartis which are also profiled in this report.
Table of Content
1. Overview1.1 Definition of Asthma
1.2 Types of Asthma
1.3 Triggers of Asthma
1.4 Treatment Options for Asthma
1.5 Chronic Obstructive Pulmonary Disease (COPD)
1.5.1 Difference between Asthma and COPD
1.5.2 Treatment Options for COPD
2. Market Analysis
2.1 Global Respiratory Market
Market Value
Market Segments
Regional Breakdown
2.1.1 Global Respiratory Therapeutics Market
Market Value
Product Segmentation
2.1.2 Global Inhalation Drug Delivery Technologies Market
Market Value
Product Segmentation
2.2 Global Asthma/COPD Market
Market Value
Prevalence Rate
Regional Breakdown
2.2.1 Global Asthma/COPD Therapeutics Market
2.3 Global Severe Asthma Market
3. Regional Markets
3.1. The U.S.
Market Overview
Diagnosed/Treated Population
3.2 European Union
Market Overview
Diagnosed/Treated Population
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Growing Global Spending on Medicines
4.1.2 Cigarette and Tobacco Consumption
4.1.3 Rising Prevalence of Non Communicable Diseases
4.1.4 Increasing Use of Biologic Drugs
4.1.5 Escalating Global GDP
4.1.6 Global Healthcare Expenditure
4.2 Key Trends and Developments
4.2.1 Launch of New Severe Asthma Drugs
4.2.2 Introduction of New COPD Drugs
4.3 Challenges
4.3.1 Increased Pricing Pressure
4.3.2 Patent Expiries and Generic Drugs
5. Competitive Landscape
5.1 Global Respiratory Market
5.2 Global Severe Asthma Market
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=363110
No comments:
Post a Comment